Cure8 news brief
Cure8 news brief
A device that can image, biopsy, and deliver therapy deeper into the small intestine could improve diagnosis and treatment access for conditions that affect that organ, including Crohn’s disease and other forms of IBD, and reduce trauma compared with existing methods.
Gastroenterologists, endoscopy teams, IBD researchers, and patients with small‑intestinal Crohn’s disease or other small‑bowel disorders who may need deep small‑bowel evaluation.
Newswise reports on a preclinical robotic enteroscope called BIOSENTER, developed by researchers at UT Southwestern and MIT. In animal/preclinical testing the snake‑inspired soft robot navigated several feet of small intestine and was used to provide real‑time imaging, take biopsies, and deliver localized fluid without visible tissue damage.
The device uses inflatable, Kevlar‑reinforced chambers for bending and kirigami (cut/folded) polymer surfaces to anchor and propel itself along the slippery intestinal mucosa. Investigators used a joystick for control in tests; they’re also exploring AI to optimize locomotion and eventual autonomous navigation.
Researchers emphasize this is early-stage, preclinical work. They note further engineering, longer-distance testing, safety validation and direct comparisons with existing double‑balloon enteroscopy are needed before human trials can begin.
This coverage describes preclinical results published in Science Robotics and summarized by the university news release; it does not report human trial data. The team highlights additional safety and usability testing, longer‑distance performance, and head‑to‑head comparisons with double‑balloon enteroscopy as next steps.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.